{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:02:08Z","timestamp":1778166128772,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.004","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T10:28:05Z","timestamp":1686392885000},"page":"4392-4401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-7345","authenticated-orcid":false,"given":"Bradley","family":"Ackerson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-9266","authenticated-orcid":false,"given":"Lina S.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6108-9198","authenticated-orcid":false,"given":"Jeff","family":"Slezak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8001-3992","authenticated-orcid":false,"given":"Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-1649","authenticated-orcid":false,"given":"Kristi","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1594-9089","authenticated-orcid":false,"given":"Runxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zendi","family":"Solano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Towner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-3180","authenticated-orcid":false,"given":"Sijia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-6830","authenticated-orcid":false,"given":"Sarah R.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-8533","authenticated-orcid":false,"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8277-2431","authenticated-orcid":false,"given":"Katia J.","family":"Bruxvoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.06.004_b0005","unstructured":"World Health Organization. Hepatitis B fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b [accessed April 1, 2022]."},{"key":"10.1016\/j.vaccine.2023.06.004_b0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.14309\/ajg.0000000000000651","article-title":"Prevalence of chronic hepatitis B virus infection in the United States","volume":"115","author":"Lim","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2023.06.004_b0015","unstructured":"Center for Disease Control and Prevention. Viral hepatitis surveillance United States; 2019. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2019surveillance [accessed April 1, 2022]."},{"key":"10.1016\/j.vaccine.2023.06.004_b0020","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2023.06.004_b0025","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1016\/j.vaccine.2011.07.030","article-title":"Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009","volume":"29","author":"Lu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.004_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations-United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2023.06.004_b0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.amepre.2009.01.037","article-title":"Physician practices regarding adult hepatitis B vaccination: a national survey","volume":"36","author":"Daley","year":"2009","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2023.06.004_b0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s15010-011-0241-2","article-title":"Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007","volume":"40","author":"Ladak","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2023.06.004_b0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the advisory committee on immunization practices for use of a hepatitis B vaccine with a novel adjuvant","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.06.004_b0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27577","article-title":"Association of number of doses with hepatitis B vaccine series completion in US adults","volume":"3","author":"Bruxvoort","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2023.06.004_b0055","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2022.2540","article-title":"Association between 2-dose vs 3-dose hepatitis B vaccine and acute myocardial infarction","volume":"327","author":"Bruxvoort","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.06.004_b0060","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.06.004_b0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.06.004_b0070","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1136\/ard.2010.129908","article-title":"Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study","volume":"69","author":"Bengtsson","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2023.06.004_b0075","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1016\/j.vaccine.2018.07.074","article-title":"Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune\/autoinflammatory syndrome induced by adjuvants' (ASIA)","volume":"36","author":"Elwood","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.004_b0080","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.vaccine.2023.06.004_b0085","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1016\/j.vaccine.2011.06.112","article-title":"Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15\u201359 years of age","volume":"29","author":"Ray","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.004_b0090","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/pds.1354","article-title":"Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study","volume":"16","author":"Yu","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2023.06.004_b0095","unstructured":"Vaccines and related biological products advisory committee meeting; July 28, 2017. https:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/UCM568492.pdf [accessed February 10, 2020]."},{"key":"10.1016\/j.vaccine.2023.06.004_b0100","unstructured":"Summary basis for regulatory action November 9, 2017. https:\/\/fda.report\/media\/108828\/November-9--2017-Approval-Letter---HEPLISAV-B.pdf [accessed February 10, 2020]."},{"key":"10.1016\/j.vaccine.2023.06.004_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data","volume":"16","author":"Koebnick","year":"2012","journal-title":"Perm J"},{"key":"10.1016\/j.vaccine.2023.06.004_b0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.vaccine.2018.06.035","article-title":"Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus","volume":"37","author":"Hechter","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.004_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2021.100101","article-title":"Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example","volume":"8","author":"Bruxvoort","year":"2021","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2023.06.004_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2023.06.004_b0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/M15-1667","article-title":"Safety of seasonal influenza vaccination in hospitalized surgical patients: a cohort study","volume":"164","author":"Tartof","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2023.06.004_b0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vaccine.2012.07.024","article-title":"Biologically plausible and evidence-based risk intervals in immunization safety research","volume":"31","author":"Rowhani-Rahbar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.004_b0135","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2084","article-title":"Safety of quadrivalent meningococcal conjugate vaccine in 11- to 21-year-olds","volume":"139","author":"Tseng","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.06.004_b0140","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.vaccine.2018.03.067","article-title":"Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults","volume":"36","author":"Hyer","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.004_b0145","unstructured":"Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021-2025). https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf [accessed April 1, 2022]."},{"key":"10.1016\/j.vaccine.2023.06.004_b0150","unstructured":"World Health Organization. Combating hepatitis B and C to reach elimination by 2030. https:\/\/www.who.int\/publications\/i\/item\/combating-hepatitis-b-and-c-to-reach-elimination-by-20302016 [accessed September 21, 2022]."},{"key":"10.1016\/j.vaccine.2023.06.004_b0155","first-page":"8","article-title":"Disparities in hepatitis B vaccine coverage by race\/ethnicity: the national health and nutrition examination survey (NHANES) 2015\u20132016","author":"Bhuiyan","year":"2020","journal-title":"Diseases"},{"key":"10.1016\/j.vaccine.2023.06.004_b0160","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis. 2019 viral hepatitis surveillance report. Atlanta, GA: US Department of Health and Human Services. https:\/\/www.cdc.gov\/hepatitis\/statistics\/SurveillanceRpts.htm2021 [accessed September 21, 2022]."},{"key":"10.1016\/j.vaccine.2023.06.004_b0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal hepatitis B vaccination in adults aged 19\u201359 years: updated recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.06.004_b0170","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1016\/j.vaccine.2018.05.111","article-title":"Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States","volume":"36","author":"Trantham","year":"2018","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:27:57Z","timestamp":1759404477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23006618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":34,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23006618"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}